Cancer Innovation

Aims & Scope

Cancer Innovation is a high-quality peer-reviewed open access journal covering key topics in all aspects of cancer research, focusing on emerging interdisciplinary, strategic frontiers and key common technologies in oncology.

The journal is dedicated to publishing innovative and significant research results in basic research and clinical oncology, including novel antitumor drugs, especially clinical trials with genetic/molecular signature data, big data-driven research on intelligent tumor diagnosis and treatment, interdisciplinary oncology innovation research and clinical translation in engineering, informatics, pharmacology, and biology.

It also includes multidisciplinary oncology research and clinical translation of oncology and other medical subspecialties, such as cardiology, neurology, respiratory medicine, fertility and other interdisciplinary integration research and co-morbidity management, and also new viewpoints, new ideas, new methods and new models of cancer prevention, diagnosis, treatment and management.

The journal focuses on the development of carcinogenesis, basic science, clinical research, and translational applications in tumor prevention and precision diagnosis and treatment, aiming to provide authoritative references and best information for oncology-related researchers, promote the development of the field of oncology, and guide innovation and medical transformation.

We sincerely welcome and accept insights and discussions from oncology scholars and experts worldwide.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,800.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Prediction of death rates for cardiovascular diseases and cancers

  Citation: 36

  Authors: Oleg, Yihan, Rajiv, Jiayao, Xiaolong

• Advances in medical treatment of breast cancer in 2022

  Citation: 31

  Authors: Jingtong, Yun, Fei, Virginia, Binghe

• Explainable artificial intelligence in breast cancer detection and risk prediction: A systematic scoping review

  Citation: 30

  Authors: Amirehsan, Soheil, David L., Arash

• Global trends of cancer: The role of diet, lifestyle, and environmental factors

  Citation: 24

  Authors: Hassan, Majid

• Applications of digital Medicine in oncology: Prospects and challenges

  Citation: 17

  Authors: Hewei, Lixi, Di, Fei

• A comprehensive review of 3D cancer models for drug screening and translational research

  Citation: 17

  Authors: Karthikey, Sreenath, Rounik, Aravind Kumar

• Organoid co‐culture models of the tumor microenvironment promote precision medicine

  Citation: 15

  Authors: Zhaoru, Quanyou, Bingqing, Kaitai, Wen

• Circular RNAs: Biomarkers of cancer

  Citation: 13

  Authors: Jingyi, Meng, Lanxin, Sida, Fei, Lihui

• Comparison of nomogram and machine‐learning methods for predicting the survival of non‐small cell lung cancer patients

  Citation: 13

  Authors: Haike, Xiaosheng, Wuren, Na, Chun, Wei, Hong, Mengchun, Ying, Guixue, Yongzhong

• Expert consensus on the clinical application of antibody‐drug conjugates in the treatment of malignant tumors (2021 edition)

  Citation: 13

  Authors: